查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612955

霍乱疫苗市场：按类型、管理方法、最终用户、年龄组别划分 - 全球预测 2025-2030

Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年霍乱疫苗市值为2.8642亿美元，预计2024年将达到3.0702亿美元，复合年增长率为7.32%，到2030年将达到4.6983亿美元。

霍乱疫苗在减轻流行全部区域霍乱疫情的影响方面发挥重要作用。疫苗市场包括Dukoral、Shanchol、Euvichol等口服疫苗，主要针对开发中国家、旅客、疫情地区的高风险族群。清洁水和卫生设施的取得有限，以及胆道疾病的持续爆发，增加了对这些疫苗的需求。疫苗主要用于流行病免疫和高风险地区的常规管理，最终用途广泛，包括公共卫生机构、非政府组织和国际免疫计画。市场成长是由意识增强、政府措施、国际资金筹措和新兴疫苗技术所推动的。最近，开发更具成本效益和更持久的疫苗的潜力为製造商与卫生组织合作并扩大其分销网络创造了机会。然而，物流挑战、低温运输限制以及人口稀少地区的意识低等限制是市场扩张的主要障碍。此外，某些国家的政治不稳定和监管核准可能会对市场的持续成长构成挑战。为了利用成长机会，公司应该在耐热配方、免疫抗原性和单剂量方案等领域进行创新，以减少后勤负担。重组口服疫苗的研究和霍乱 mRNA 平台的探索可能会改变预防策略。市场渗透需要多样化且价格实惠的产品系列以及与公共卫生机构的策略合作伙伴关係。市场仍然充满活力，定期爆发会导致需求激增，营运商需要灵活应对这些波动。了解当地疾病负担和未满足的需求可以引导成功的市场进入并确保在当前挑战下实现持续成长。

主要市场统计
基准年[2023] 2.8642亿美元
预测年份 [2024] 30702万美元
预测年份 [2030] 46983万美元
复合年增长率（%） 7.32%

市场动态：快速发展的霍乱疫苗市场的关键市场洞察

供需的动态交互作用正在改变霍乱疫苗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球霍乱病例数不断增加
    • 政府支持霍乱疫苗接种宣传活动
  • 市场限制因素
    • 疫苗研发成本高及产品短缺问题
  • 市场机会
    • 重组DNA技术与细胞生产系统的开发
    • 霍乱疫苗包装与储存解决方案的创新
  • 市场挑战
    • 全球缺乏熟练的医疗保健专业人员

波特的五力：驾驭霍乱疫苗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解霍乱疫苗市场的外部影响

外部宏观环境因素对霍乱疫苗市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解霍乱疫苗市场的竞争状况

霍乱疫苗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵霍乱疫苗市场供应商的绩效评估

FPNV定位矩阵是评估霍乱疫苗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製霍乱疫苗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，霍乱疫苗市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地霍乱感染人数不断增加
      • 政府支持霍乱疫苗接种的广告宣传活动
    • 抑制因素
      • 疫苗研发高成本、产品短缺问题
    • 机会
      • 重组 DNA 技术与细胞生产系统的进展
      • 霍乱疫苗包装与储存解决方案的创新
    • 任务
      • 全球缺乏熟练的医疗保健专业人员
  • 市场区隔分析
    • 类型：减毒疫苗的采用率很高，因为它们能够刺激强烈的免疫反应
    • 最终用户：政府免疫计画变得越来越重要，重点是教育人们霍乱预防方法和疫苗接种的重要性。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章霍乱疫苗市场：依类型

  • 灭活疫苗
  • 减毒活疫苗

第七章 依给药方式分類的霍乱疫苗市场

  • 注射疫苗
  • 口服疫苗

第八章霍乱疫苗市场：依最终用户分类

  • 政府疫苗接种计划
  • 医院/诊所

第九章霍乱疫苗市场：依年龄组

  • 成人
  • 孩子们

第十章美洲霍乱疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区霍乱疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的霍乱疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 霍乱疫苗接种策略技术转移：IVI 与 Biological E. Limited 之间的合作
    • GC Biopharma 与 Eubiologics 就霍乱疫苗生产建立策略联盟
    • TechInvention 与 Eubiologics 合作在印度推出创新霍乱疫苗包装
  • 战略分析和建议

公司名单

  • Astellas Pharma Inc.
  • Beijing Minhai Biological Technology Co., Ltd.
  • Bharat Biotech Ltd.
  • Bio-Manguinhos
  • Biological E Ltd
  • BioVac by Ceva Sante Animale
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Haffkine Bio-Pharmaceutical Corporation Ltd
  • Incepta Pharmaceuticals Ltd.
  • Merck & Co. Inc
  • Panacea Biotec Ltd
  • Sanofi SA
  • SK Inc.
  • Techinvention Lifecare Pvt. Ltd.
  • Valneva SE
Product Code: MRR-5D693B46BD1B

The Cholera Vaccines Market was valued at USD 286.42 million in 2023, expected to reach USD 307.02 million in 2024, and is projected to grow at a CAGR of 7.32%, to USD 469.83 million by 2030.

Cholera vaccines play a critical role in mitigating the impact of cholera outbreaks across endemic regions. The vaccine market encompasses oral vaccines such as Dukoral, Shanchol, and Euvichol, primarily targeting high-risk populations in developing countries, travelers, and regions experiencing outbreaks. There's a rising necessity for these vaccines driven by persistent choleral outbreaks due to limited access to clean water and sanitation. The application of vaccines mainly spans prophylactic immunization during epidemics and routine administration in high-risk areas, with end-use across public health agencies, NGOs, and international vaccination programs. Market growth is propelled by increased awareness, government initiatives, international funding, and emerging vaccine technologies. Recently, there is potential for cost-effective, longer-lasting vaccines, fostering opportunities for manufacturers to partner with health organizations to expand distribution networks. Nevertheless, limitations include logistical challenges, cold chain constraints, and a lack of awareness in underdeveloped areas which pose as significant barriers to market expansion. Additionally, political instability and regulatory approvals in certain countries can challenge consistent market growth. To capitalize on growth opportunities, businesses should innovate in fields like thermostable formulations, enhanced immunogenicity, and single-dose regimens to reduce logistical burdens. Research into genetically engineered oral vaccines and exploring the mRNA platform for cholera could transform prevention strategies. A diverse, affordable product portfolio and strategic collaborations with public health agencies are necessary for market penetration. The market remains dynamic with periodic demand spikes driven by outbreaks, and operators must stay agile to respond to these fluctuations. Understanding regional disease burden and unmet needs can guide successful market entries and ensure sustainable growth despite current challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 286.42 million
Estimated Year [2024] USD 307.02 million
Forecast Year [2030] USD 469.83 million
CAGR (%) 7.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cholera Vaccines Market

The Cholera Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of cholera cases across the globe
    • Supportive government promotional campaigns for cholera vaccination
  • Market Restraints
    • High cost of vaccine development coupled with issues of product shortages
  • Market Opportunities
    • Developments in recombinant DNA technology and cell-based production systems
    • Innovations in packaging and storage solutions for cholera vaccines
  • Market Challenges
    • Limited availability of skilled healthcare professionals worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Cholera Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cholera Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cholera Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cholera Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cholera Vaccines Market

A detailed market share analysis in the Cholera Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cholera Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cholera Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cholera Vaccines Market

A strategic analysis of the Cholera Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cholera Vaccines Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Beijing Minhai Biological Technology Co., Ltd., Bharat Biotech Ltd., Bio-Manguinhos, Biological E Ltd, BioVac by Ceva Sante Animale, Emergent BioSolutions Inc., GlaxoSmithKline plc, Haffkine Bio-Pharmaceutical Corporation Ltd, Incepta Pharmaceuticals Ltd., Merck & Co. Inc, Panacea Biotec Ltd, Sanofi S.A., SK Inc., Techinvention Lifecare Pvt. Ltd., and Valneva SE.

Market Segmentation & Coverage

This research report categorizes the Cholera Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Inactivated Vaccine and Live Attenuated Vaccine.
  • Based on Method of Administration, market is studied across Injectable Vaccines and Oral Vaccines.
  • Based on End User, market is studied across Government Vaccination Programs and Hospitals & Clinics.
  • Based on Age Group, market is studied across Adults and Children.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cholera cases across the globe
      • 5.1.1.2. Supportive government promotional campaigns for cholera vaccination
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of vaccine development coupled with issues of product shortages
    • 5.1.3. Opportunities
      • 5.1.3.1. Developments in recombinant DNA technology and cell-based production systems
      • 5.1.3.2. Innovations in packaging and storage solutions for cholera vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled healthcare professionals worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Higher adoption of attenuated vaccines owing to their ability to stimulate strong immune responses
    • 5.2.2. End User: Growing significance of Government vaccination programs, focusing on educating people about cholera prevention methods and the importance of vaccination
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cholera Vaccines Market, by Type

  • 6.1. Introduction
  • 6.2. Inactivated Vaccine
  • 6.3. Live Attenuated Vaccine

7. Cholera Vaccines Market, by Method of Administration

  • 7.1. Introduction
  • 7.2. Injectable Vaccines
  • 7.3. Oral Vaccines

8. Cholera Vaccines Market, by End User

  • 8.1. Introduction
  • 8.2. Government Vaccination Programs
  • 8.3. Hospitals & Clinics

9. Cholera Vaccines Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adults
  • 9.3. Children

10. Americas Cholera Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cholera Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cholera Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Strategic Technology Transfer in Cholera Vaccination: A Partnership Between IVI and Biological E. Limited
    • 13.3.2. Strategic Collaboration for Cholera Vaccine Production between GC Biopharma and Eubiologics
    • 13.3.3. TechInvention Introduces Innovative Cholera Vaccine Packaging in India with Eubiologics Partnership
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Astellas Pharma Inc.
  • 2. Beijing Minhai Biological Technology Co., Ltd.
  • 3. Bharat Biotech Ltd.
  • 4. Bio-Manguinhos
  • 5. Biological E Ltd
  • 6. BioVac by Ceva Sante Animale
  • 7. Emergent BioSolutions Inc.
  • 8. GlaxoSmithKline plc
  • 9. Haffkine Bio-Pharmaceutical Corporation Ltd
  • 10. Incepta Pharmaceuticals Ltd.
  • 11. Merck & Co. Inc
  • 12. Panacea Biotec Ltd
  • 13. Sanofi S.A.
  • 14. SK Inc.
  • 15. Techinvention Lifecare Pvt. Ltd.
  • 16. Valneva SE

LIST OF FIGURES

  • FIGURE 1. CHOLERA VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. CHOLERA VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CHOLERA VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CHOLERA VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHOLERA VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHOLERA VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GOVERNMENT VACCINATION PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. CHOLERA VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. CHOLERA VACCINES MARKET, FPNV POSITIONING MATRIX, 2023